Bristol Myers Squibb
Information
BMS is one of the largest biopharmaceutical companies in the world. The new cell therapy facility at the Leiden Bio Science Park (LBSP) will be its fifth such facility in the world and its first European one. Its aim is to bring cell therapy closer to European patients. The facility will have the latest technology and production equipment for cell therapy development, thus enabling the company to increase its capacity for treating cancer patients.
BMS is one of the largest biopharmaceutical companies in the world. The new cell therapy facility at the Leiden Bio Science Park (LBSP) will be its fifth such facility in the world and its first European one. Its aim is to bring cell therapy closer to European patients. The facility will have the latest technology and production equipment for cell therapy development, thus enabling the company to increase its capacity for treating cancer patients.
Location
-
2021-2024
Run time
-
Life, Science & Health
Type
-
Gemeente Leiden Universiteit Leiden
Landowner
-
19.000 m2
Surface area
- Credits Architect: KuiperCompagnons
- Roadworks Roadworks may affect traffic in the local area. For more information, please press the red button ‘All roadworks’.
Comparable projects
-
Completed HALIXThe growing biopharmaceutical company HALIX has acquired a new medical production testing ... -
Completed Plus Ultra LeidenA new multi-tenant building by Kadans Science Partner at the entrance to the Bio Science P... -
Completed SRONTo the north of the Gorlaeus, the construction of the new headquarters for SRON (the Nethe...